SIM
DCPH

Spark Investment Management’s Deciphera Pharmaceuticals, Inc. Common Stock DCPH Stock Holding History

Spark Investment Management’s Portfolio DCPH Stock Details DCPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-9,625
Closed -$599K – 556
2019
Q4 		$599K Sell
9,625
-10,875
-53% -$517K 0.07% 325
2019
Q3 		$695K Buy
20,500
+8,600
+72% +$255K 0.09% 221
2019
Q2 		$268K Buy
+11,900
New +$279K 0.02% 434

Other funds holding DCPH

RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Spark Investment Management's DCPH Position: Q1 2020 in Review

Spark Investment Management sold out of Deciphera Pharmaceuticals, Inc. Common Stock (DCPH) in Q1 2020, closing a stake of 9,625 shares — an estimated $599K sold.

Spark Investment Management first reported a position in DCPH in Q2 2019 and held it in 3 quarters. The position peaked at $695K in Q3 2019. 148 funds tracked by Wall St. Rank hold DCPH as of Q1 2020.

  • Spark Investment Management reported no remaining Deciphera Pharmaceuticals, Inc. Common Stock position as of Q1 2020 after selling out during the quarter.
  • Spark Investment Management sold 9,625 Deciphera Pharmaceuticals, Inc. Common Stock shares in Q1 2020, an estimated $599K.
  • Spark Investment Management first reported a position in Deciphera Pharmaceuticals, Inc. Common Stock in Q2 2019 and held it in 3 quarters.
  • Spark Investment Management's Deciphera Pharmaceuticals, Inc. Common Stock position peaked at $695K in Q3 2019.
  • 148 funds tracked by Wall St. Rank held Deciphera Pharmaceuticals, Inc. Common Stock as of Q1 2020.

Based on Spark Investment Management's 13F filing for Q1 2020, filed 12 May 2020.